181 related articles for article (PubMed ID: 30356861)
1. Alpha-synuclein overexpression in the olfactory bulb initiates prodromal symptoms and pathology of Parkinson's disease.
Niu H; Shen L; Li T; Ren C; Ding S; Wang L; Zhang Z; Liu X; Zhang Q; Geng D; Wu X; Li H
Transl Neurodegener; 2018; 7():25. PubMed ID: 30356861
[TBL] [Abstract][Full Text] [Related]
2. Perturbation of in vivo Neural Activity Following α-Synuclein Seeding in the Olfactory Bulb.
Kulkarni AS; Del Mar Cortijo M; Roberts ER; Suggs TL; Stover HB; Pena-Bravo JI; Steiner JA; Luk KC; Brundin P; Wesson DW
J Parkinsons Dis; 2020; 10(4):1411-1427. PubMed ID: 32925105
[TBL] [Abstract][Full Text] [Related]
3. Adenovirus-induced Reactive Astrogliosis Exacerbates the Pathology of Parkinson's Disease.
An H; Lee H; Yang S; Won W; Lee CJ; Nam MH
Exp Neurobiol; 2021 Jun; 30(3):222-231. PubMed ID: 34045369
[TBL] [Abstract][Full Text] [Related]
4. Ciita Regulates Local and Systemic Immune Responses in a Combined rAAV-α-synuclein and Preformed Fibril-Induced Rat Model for Parkinson's Disease.
Fredlund F; Jimenez-Ferrer I; Grabert K; Belfiori L; Luk KC; Swanberg M
J Parkinsons Dis; 2024 May; ():. PubMed ID: 38728204
[TBL] [Abstract][Full Text] [Related]
5. Air pollution nanoparticle and alpha-synuclein fibrils synergistically decrease glutamate receptor A1, depending upon nPM batch activity.
Zhang H; D'Agostino C; Tulisiak C; Thorwald MA; Bergkvist L; Lindquist A; Meyerdirk L; Schulz E; Becker K; Steiner JA; Cacciottolo M; Kwatra M; Rey NL; Escobar Galvis ML; Ma J; Sioutas C; Morgan TE; Finch CE; Brundin P
Heliyon; 2023 Apr; 9(4):e15622. PubMed ID: 37128335
[TBL] [Abstract][Full Text] [Related]
6. Transmission of α-synucleinopathy from olfactory structures deep into the temporal lobe.
Mason DM; Nouraei N; Pant DB; Miner KM; Hutchison DF; Luk KC; Stolz JF; Leak RK
Mol Neurodegener; 2016 Jun; 11(1):49. PubMed ID: 27363576
[TBL] [Abstract][Full Text] [Related]
7. IGF2 prevents dopaminergic neuronal loss and decreases intracellular alpha-synuclein accumulation in Parkinson's disease models.
Arcos J; Grunenwald F; Sepulveda D; Jerez C; Urbina V; Huerta T; Troncoso-Escudero P; Tirado D; Perez A; Diaz-Espinoza R; Nova E; Kubitscheck U; Rodriguez-Gatica JE; Hetz C; Toledo J; Ahumada P; Rojas-Rivera D; Martín-Montañez E; Garcia-Fernandez M; Vidal RL
Cell Death Discov; 2023 Dec; 9(1):438. PubMed ID: 38042807
[TBL] [Abstract][Full Text] [Related]
8. Cortical Lewy body injections induce long-distance pathogenic alterations in the non-human primate brain.
Teil M; Dovero S; Bourdenx M; Arotcarena ML; Darricau M; Porras G; Thiolat ML; Trigo-Damas I; Perier C; Estrada C; Garcia-Carrillo N; Herrero MT; Vila M; Obeso JA; Bezard E; Dehay B
NPJ Parkinsons Dis; 2023 Sep; 9(1):135. PubMed ID: 37726343
[TBL] [Abstract][Full Text] [Related]
9. Aggregate-prone brain regions in Parkinson's disease are rich in unique N-terminus α-synuclein conformers with high proteolysis susceptibility.
Wiseman JA; Murray HC; Faull RLMF; Dragunow M; Turner CP; Dieriks BV; Curtis MA
NPJ Parkinsons Dis; 2024 Jan; 10(1):1. PubMed ID: 38167744
[TBL] [Abstract][Full Text] [Related]
10. "Janus-Faced" α-Synuclein: Role in Parkinson's Disease.
Ray B; Mahalakshmi AM; Tuladhar S; Bhat A; Srinivasan A; Pellegrino C; Kannan A; Bolla SR; Chidambaram SB; Sakharkar MK
Front Cell Dev Biol; 2021; 9():673395. PubMed ID: 34124057
[TBL] [Abstract][Full Text] [Related]
11. Dysfunction of the noradrenergic system drives inflammation, α-synucleinopathy, and neuronal loss in mouse colon.
Song S; Tu D; Meng C; Liu J; Wilson B; Wang Q; Shih YI; Gao HM; Hong JS
Front Immunol; 2023; 14():1083513. PubMed ID: 36845109
[TBL] [Abstract][Full Text] [Related]
12. NRF2 Loss Accentuates Parkinsonian Pathology and Behavioral Dysfunction in Human α-Synuclein Overexpressing Mice.
Anandhan A; Nguyen N; Syal A; Dreher LA; Dodson M; Zhang DD; Madhavan L
Aging Dis; 2021 Jul; 12(4):964-982. PubMed ID: 34221542
[TBL] [Abstract][Full Text] [Related]
13. Distribution of phosphorylated alpha-synuclein in non-diseased brain implicates olfactory bulb mitral cells in synucleinopathy pathogenesis.
Killinger BA; Mercado G; Choi S; Tittle T; Chu Y; Brundin P; Kordower JH
NPJ Parkinsons Dis; 2023 Mar; 9(1):43. PubMed ID: 36966145
[TBL] [Abstract][Full Text] [Related]
14. Transcriptional mutagenesis of α-synuclein caused by DNA oxidation in Parkinson's disease pathogenesis.
Basu S; Song M; Adams L; Jeong I; Je G; Guhathakurta S; Jiang J; Boparai N; Dai W; Cardozo-Pelaez F; Tatulian SA; Han KY; Elliott J; Baum J; McLean PJ; Dickson DW; Kim YS
Acta Neuropathol; 2023 Nov; 146(5):685-705. PubMed ID: 37740734
[TBL] [Abstract][Full Text] [Related]
15. Neither alpha-synuclein-preformed fibrils derived from patients with
Walton S; Fenyi A; Tittle T; Sidransky E; Pal G; Choi S; Melki R; Killinger BA; Kordower JH
bioRxiv; 2023 Aug; ():. PubMed ID: 37662402
[TBL] [Abstract][Full Text] [Related]
16. Immunization Effects of a Novel α-Synuclein-Based Peptide Epitope Vaccine in Parkinson's Disease-Associated Pathology.
Park JS; Ahmad R; Choe K; Kang MH; Park TJ; Kim MO
Vaccines (Basel); 2023 Dec; 11(12):. PubMed ID: 38140224
[TBL] [Abstract][Full Text] [Related]
17. Lack of Parkinsonian Pathology and Neurodegeneration in Mice After Long-Term Injections of a Proteasome Inhibitor in Olfactory Bulb and Amygdala.
Del Rey NL; Balzano T; Martin-Rodriguez L; Salinas-Rebolledo C; Trigo-Damas I; Rojas-Fernandez A; Alvarez-Erviti L; Blesa J
Front Aging Neurosci; 2021; 13():698979. PubMed ID: 34744683
[TBL] [Abstract][Full Text] [Related]
18. Detecting Misfolded α-Synuclein in Blood Years before the Diagnosis of Parkinson's Disease.
Kluge A; Schaeffer E; Bunk J; Sommerauer M; Röttgen S; Schulte C; Roeben B; von Thaler AK; Welzel J; Lucius R; Heinzel S; Xiang W; Eschweiler GW; Maetzler W; Suenkel U; Berg D
Mov Disord; 2024 Apr; ():. PubMed ID: 38651526
[TBL] [Abstract][Full Text] [Related]
19. Prodromal Parkinson's disease and the catecholaldehyde hypothesis: Insight from olfactory bulb organotypic cultures.
Bagnoli E; Trotier A; McMahon J; Quinlan LR; Biggs M; Pandit A; FitzGerald U
FASEB J; 2023 Dec; 37(12):e23272. PubMed ID: 37997495
[TBL] [Abstract][Full Text] [Related]
20. Alpha-synuclein pre-formed fibrils injected into prefrontal cortex primarily spread to cortical and subcortical structures and lead to isolated behavioral symptoms.
Weber MA; Kerr G; Thangavel R; Conlon MM; Abdelmotilib HA; Halhouli O; Zhang Q; Geerling JC; Narayanan NS; Aldridge GM
bioRxiv; 2023 May; ():. PubMed ID: 36778400
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
